Outsourcing provider, PCI Pharma Services, has made further investments in its specialised labelling capabilities at its Hay-on-Wye site in the UK.
Investment
To meet with increasing market demand for specialised labelling, PCI has partnered with Marchesini Group to develop a bespoke, automated labelling solution. Marchesini, a manufacturer of pharmaceutical packaging equipment, designed a custom-built technology based on an existing labeller and some standard modules, which is capable of handling both standard and custom-moulded syringes as well as auto-injectors.
“Following a comprehensive review of potential suppliers, Marchesini was appointed for this project based on both our existing relationship combined with its reputation as market leaders in this field. The excellent working partnership between the PCI and Marchesini teams led to the design and construction of the equipment being completed in only nine months from start to finish,” commented Colin White, PCI’s managing director at Hay-on-Wye. “As this is a completely bespoke technology, we are rightly proud that it is the only one that exists in any CDMO globally, meaning we really are able to offer best-in-class solutions for our customers. The high number of enquiries we have already received reflects the clear market demand for such advanced labelling solutions.”
The new labeller is expected to be fully operational and validated at the Hay-on-Wye site this month and has been built to achieve EU, FDA and Japanese quality standards for PCI production.